Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases

Current Opinion in Hematology

Volumn 10, Issue 6, 2003, Pages 405-411

  Cable, Ritchard G ^a,b,e   Leiby, David A ^c,d  

^a AMERICAN RED CROSS   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c HOLLAND LABORATORY   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

Babesiosis; Blood transfusion; Ehrlichiosis; Ticks

Indexed keywords

BABESIA MICROTI; BABESIOSIS; BLOOD DONOR; BLOOD TRANSFUSION REACTION; EHRLICHIOSIS; HUMAN; INFECTION RISK; LYME DISEASE; PARASITE TRANSMISSION; PREVALENCE; PRIORITY JOURNAL; RECREATION; REVIEW; SAFETY; SPECIES ENDEMICITY; TICK BITE; TICK BORNE DISEASE; UNITED STATES;

ANIMALS; BABESIOSIS; BLOOD TRANSFUSION; HUMANS; RISK; TICK-BORNE DISEASES;

EID: 0242361756     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200311000-00002     Document Type: Review

References (63)

1. Gellfand JA, Callahan MV: Babesiosis: an update on epidemiology and treatment. Curr Infect Dis Rep 2003, 5:53-58.
2. Krause PJ: Tick-borne diseases. Med Clin North Am 2002, 86:361-373.
3. Kjemtrup A, Scholtens RG, Braff EH, et al.: A case of babesiosis in man in the United States. Am J Trop Med Hyg 1968, 17:810-813.
4. Scholtens RG, Braff EH, Healy GR, et al.: A case of babesiosis in man in the United States. Am J Trop Med Hyg 1968, 17:810-813.
5. McQuiston JH, Childs JE, Chamberland ME, et al.: Transmission of tick-borne agents by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000, 40:274-284.
6. White DJ, Talarico J, Chang HG, et al.: Human babesiosis in New York State. Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998, 158:2149-2154.
7. Herwaldt BL, McGovern PC, Gerwel MP, et al.: Endemic babesiosis in another eastern state. New Jersey. Emerg Infect Dis 2003, 9:184-188. This article describes 40 cases of endemic babesiosis acquired in Central New Jersey from 1993 to 2001.
8. Quick RE, Herwaldt BL, Thromford JW, et al.: Babesiosis in Washington State: a new species of Babesia? Ann Intern Med 1993, 119:284-290.
9. Persing DH, Herwaldt BL, Glaser C, et al.: Infection with a Babesia-like organism in northern California. N Engl J Med 1995, 332:298-303.
10. Herwaldt BL, Persing DH, Précigout EA, et al.: A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996, 124:643-650.
11. Beattie JF, Michelson ML, Holman PJ: Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 2002, 347:697-698. The authors report an acute case of babesiosis in a Kentucky resident caused by B. divergens. The report adds to our understanding of the diversity of Babesia species known to infect humans in the United States and may be particularly important because of the reported clinical severity of B. divergens infection.
12. Homer MJ, Aguilar-Delfin I, Telford SR, et al.: Babesiosis. Clin Microbiol Rev 2000, 13:451-469.
13. Gorenflot A, Moubri K, Précigout E, et al.: Human babesiosis. Ann Trop Med Parasitol 1998, 92:489-501.
14. Hunfeld KP, Lambert A, Kampen H, et al.: Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol 2002, 40:2431-2436. This article describes an unexpectedly high seroprevalence of antibody to B. microti in a Lyme disease endemic area of Germany. It is surprising that transfusion babesiosis has not been reported in Europe.
15. Saito-Ito A, Tsuji M, Wei Q, et al.: Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with huRBC-SCID mice. J Clin Microbiol 2000, 38:4511-4516.
16. Meldrum SC, Birkhead GS, White DJ, et al.: Human babesiosis in New York State: an epidemiologic description of 136 cases. Clin Infect Dis 1992, 15:1019-1023.
17. Sun T, Tenenbaum MJ, Greenspan J, et al.: Morphologic and clinical observations in human infection with Babesia microti. J Infect Dis 1983, 148:239-248.
18. Chisholm ES, Ruebush TK, Sulzer AJ, et al.: Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 1978, 27:14-19.
19. Ryan R, Krause PJ, Radolf J, et al.: Diagnosis of babesiosis using an immunoblot serologic test. Clin Diagn Immunol 2001, 8:1177-1180.
20. Houghton RL, Homer MJ, Reynolds LD, et al.: Identification of Babesia microti-specific immunodominant epitopes and development of a peptide EIA for detection of antibodies in serum. Transfusion 2002, 42:1488-1496. This article reports the development of a prototype peptide enzyme immunoassay for B. microti-specific antibodies and its preliminary performance characteristics in sera before and after infection in 59 individuals with known tick-borne infection. The reactivity showed a high correlation with B. microti immunofluorescent assay and immunoblot, suggesting that the peptide enzyme immunoassay may be a suitable candidate assay for development into an automated blood donor screening method.
21. Homer MJ, Lodes MJ, Reynolds LD, et al.: Identification and characterization of putative secreted antigens from Babesia microti. J Clin Microbiol 2003, 41:723-729. This article supplements reference 20 by demonstrating the elaboration of specific antigenically detectable peptides into the serum of mice infected with B. microti.
22. Persing DH, Mathiesen D, Marshall WF, et al.: Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992, 30:2097-2103.
23. Olmeda AS, Armstrong PM, Rosenthal BM, et al.: A subtropical case of human babesiosis. Acta Trop 1997, 67:229-234.
24. Herwaldt BL, Kjemtrup AM, Conrad PA, et al.: Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J Infect Dis 1997, 175:1259-1262.
25. Krause PJ, Spielman A, Telford SR, et al.: Persistent parasitemia after acute babesiosis. N Engl J Med 1998, 339:160-164.
26. Popovsky MA, Lindberg LE, Syrek AL, et al.: Prevalence of Babesia antibody in a selected blood donor population. Transfusion 1988, 28:59-61.
27. Linden JV, Wong SJ, Chu FK, et al.: Transfusion-associated transmission of babesiosis in New York State. Transfusion 2000, 40:285-289.
28. Leiby DA, Chung APS, Cable RG, et al.: Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion 2002, 42:1585-1591. This article assesses the seroprevalence of antibodies to these two tick-borne agents in blood donors in Connecticut and Wisconsin and demonstrates that a history of tick exposure does not predict higher seroprevalence for B. microti. It also demonstrates by donor survey that recent exposure to ticks is reported by up to 9% of blood donors in geographically representative blood centers.
29. Fritz CL, Kjemtrup AM, Conrad PA, et al.: Seroepidemiology of emerging tick-borne infectious diseases in a Northern California community. J Infect Dis 1997, 175:1432-1439.
30. Lux JZ, Weiss D, Linden JV, et al.: Transfusion-associated babesiosis after heart transplant. Emerg Infect Dis 2003, 9:116-119. This is a case report of apparent transfusion babesiosis after a heart transplant in New York City. One of 32 red blood cell donors had a positive antibody titer for B. microti, but was negative by PCR and hamster inoculation 5 months after their donation. Serum from the heart donor, a lifelong New York City resident, was unavailable for testing. The case illustrates some of the difficulties in establishing a transfusion cause for the infection.
31. Matsui T, Inoue R, Kajimoto K, et al.: First documentation of transfusion-associated babesiosis in Japan [In Japanese with English summary]. Rinsho Ketsueki 2000, 41:628-634.
32. Wei Q, Tsuji M, Zamoto A, et al.: Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic. J Clin Microbiol 2001, 39:2178-2183.
33. Jassoum BS, Fong IW, Hannach B, et al.: Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. Can Commun Dis Rep 2000, 26:9-13.
34. Kjemtrup AM, Lee B, Fritz CL, et al.: Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 2002, 42:1482-1487. This article reports the second reported case of transfusion-transmitted WA-1, occurring in California from a donor infected during a camping trip in Central Oregon. Transfusion babesiosis with B. microti in premature infants has been previously reported. The case report illustrates the use of hamster inoculation to isolate the responsible piroplasm, to exclude the mother as the source of the infection, and to identify an identical organism in the implicated donor.
35. Pantanowitz L, Telford SR, Cannon ME: The impact of babesiosis on transfusion medicine. Transfusion Med Rev 2002, 16:131-143.
36. Cable RG, Trouern-Trend J: Tick-borne infections. In: Blood Safety and Surveillance. Edited by Linden JV, Bianco C. New York: Marcel Dekker; 2001:399-422.
37. Slovut DP, Benedetti F, Matas AJ: Babesiosis and hemophagocytic syndrome in an asplenic renal transplant recipient. Transplantation 1996, 62:537-539.
38. Perdrizet GA, Olson NH, Krause PJ, et al.: Babesiosis in a renal transplant recipient acquired through blood transfusion. Transplantation 2000, 70:205-208.
39. Pantanowitz L, Cannon ME: Extracellular Babesia microti parasites. Transfusion 2001, 41:440.
40. Herwaldt BL, Neitzel DF, Gorlin JB, et al.: Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion 2002, 42:1154-1158. This report illustrates the ability of asymptomatic blood donors to carry B. microti for many months and thus be capable of infecting recipients over a series of blood donations over time. This article and reference 41 illustrate the importance of Lookback when an infected donor is identified.
41. Cable RG, Trouern-Trend J, Badon SJ, et al.: Lookback on donors found seropositive for B. microti: an 11 year experience in an endemic area for babesiosis [abstract]. Transfusion 2003, 43(suppl):13A. This abstract reports on Lookback on the recipients of recent blood donations from 54 blood donors found to be seropositive for B. microti. Twenty-six percent of tested recipients of red blood cells and 22% of all tested recipients of cellular products were found to be seropositive. Such identified recipients should be evaluated for parasitemia and for clinical symptoms of babesiosis and should be appropriately managed.
42. Gerber MA, Shapiro ED, Krause PJ, et al.: The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis 1994, 170:231-234.
43. Cable RG, Badon S, Trouern-Trend J, et al.: Evidence for transmission of Babesia microti from Connecticut blood donors to recipients [Abstract]. Transfusion 2001, 41(suppl):12S-13S.
44. Badon S, Trouern-Trend J, Cable R: Eleven years of experience investigating suspected post-transfusion babesiosis [Abstract]. Transfusion 2003, 43(suppl):78A. This abstract summarizes 18 reported cases of transfusion babesiosis during an 11-year period in Connecticut. The cases represent the transfusion of approximately 1.8 million red blood cells, resulting in a reported incidence rate of 1 clinically recognized case of babesiosis for every 100,000 red blood cell transfusions in this endemic area. The majority of the cases could be traced to a specific blood donor, although in three cases no donor was identified (and could represent tickborne babesiosis), and in two cases the investigation of all donors could not be completed.
45. Standards for Blood Banks and Transfusion Services: 22nd ed. Bethesda, MD: American Association of Blood Banks; 2003.
46. Strle F, Nadelman RB, Cimperman J, et al.: Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzellii in Slovenia. Ann Intern Med 1999, 130:32-36.
47. White DJ, Talarico J, Chang H, et al.: Human babesiosis in New York State. Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998, 158:2149-2154.
48. Fishbein DB, Dawson JE, Robinson LA: Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994, 120:736-743.
49. Grellier P, Santus R, Louray E, et al.: Photosensitized inactivation of Plasmodium falciparum-and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang 1997, 72:211-220.
50. Randall WH, Simmons J, Casper EA, et al.: Transmission of Colorado tick fever virus by blood transfusion-Montana. Morb Mortal Wkly Rep 1975, 24:422-427.
51. Summary of Notifiable Diseases-United States: 2000. Morb Mortal Wkly Rep 2002;49:x-xi.
52. Dumler JS, Bakken JS: Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995, 20:1102-1110.
53. Bakken JS, Dumler JS: Human granulocytic ehrlichiosis. Clin Infect Dis 2000, 31:554-560.
54. Walls JJ, Aguero-Rosenfeld M, Bakken JS, et al.: Inter-and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by immunofluorescent-antibody test. J Clin Microbiol 1999, 37:2968-2973.
55. Everett ED, Evans KA, Henry RB, et al.: Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994, 120:730-735.
56. Massung RF, Slater K, Owens JH, et al.: Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol 1998, 36:1090-1095.
57. Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, et al.: Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol 2002, 40:2612-2615.
58. Eastlund T, Persing D, Mathiesen D, et al.: Human granulocytic ehrlichiosis after red cell transfusion [Abstract]. Transfusion 1999, 39(suppl):117S.
59. Kalantarpour F, Chowdhury I, Wormser GP, et al.: Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin Microbiol 2000, 38:2398-2399.
60. Shrestha M, Grodzicki RL, Steere AC: Diagnosing early Lyme disease. Am J Med 1985, 78:235-240.
61. Badon SJ, Cable RG, Morse EE, et al.: Evidence of Borrelia burgdorferi in a blood donation. Blood 1995, 86(suppl 1):355a.
62. Cable R, Krause P, Badon S, et al.: Acute blood donor co-infection with Babesia microti (Bm) and Borrelia burgdorferi (Bb). Transfusion 1993, 33(suppl):50S.
63. Badon SJ, Fister RD, Cable RG: Survival of Borrelia burgdorferi in blood products. Transfusion 1989, 29:581-583.